The exhibition centre hosts the international event – renowned as 'the heart of pharma' – in Europe's premier pharma manufacturing region CPHI, the world's largest ...

Novo Nordisk is hiking projections for its fast-selling diabetes and obesity drugs even higher following results showing one of them, Wegovy, can reduce the risk of h...

The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken without her knowledge ...

Dive Brief: The Food and Drug Administration has conditionally approved a new medicine for multiple myeloma, offering patients with hard-to-treat forms of the bloo...

Dive Brief: Novo Nordisk agreed to buy metabolic disorder specialist Inversago Pharma in a deal worth as much as about $1.1 billion as the Danish company works to ...

Celebrating the innovation, scientific successes, and personal achievements of their community is extremely important to them. ELRIG are proud to be able to showcase ...

Scientific Centre of Excellence aims to accelerate Revvity’s fundamental commitment of revolutionizing health science for a healthier humankind Focused on impr...

On Thursday, the Food and Drug Administration awarded a full approval to the Alzheimer’s disease treatment Leqembi, a decision expected to significantly increase use ...

Dive Brief: Pfizer bought $25 million worth of stock in Caribou Biosciences, giving the gene-editing company a vote of confidence and a boost of funding for an exp...

BioMarin Pharmaceutical, having secured a long-awaited approval from the Food and Drug Administration, says its focus has now turned to launching its new hemophilia g...